Literature DB >> 21998430

Xpert MTB/RIF assay for diagnosis of pleural tuberculosis.

Sven O Friedrich1, Florian von Groote-Bidlingmaier, Andreas H Diacon.   

Abstract

We prospectively investigated the diagnostic utility of the Xpert MTB/RIF (Mycobacterium tuberculosis/rifampin [RIF] resistance) assay in 20 cases with confirmed tuberculous pleural effusion. The sensitivity and specificity of the Xpert assay in pleural fluid were 25% and 100%, respectively. All cases positive by the Xpert assay were also positive by pleural fluid culture.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21998430      PMCID: PMC3232996          DOI: 10.1128/JCM.05454-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

2.  Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system.

Authors:  Doris Hillemann; Sabine Rüsch-Gerdes; Catharina Boehme; Elvira Richter
Journal:  J Clin Microbiol       Date:  2011-01-26       Impact factor: 5.948

3.  Comparison of two molecular methods for rapid diagnosis of extrapulmonary tuberculosis.

Authors:  Manuel Causse; Pilar Ruiz; Juan Bautista Gutiérrez-Aroca; Manuel Casal
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

Review 4.  Update on tuberculous pleural effusion.

Authors:  Richard W Light
Journal:  Respirology       Date:  2010-03-21       Impact factor: 6.424

5.  Suitability of Xpert MTB/RIF and genotype MTBDRplus for patient selection for a tuberculosis clinical trial.

Authors:  Sven O Friedrich; Amour Venter; Xavier A Kayigire; Rodney Dawson; Peter R Donald; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2011-06-08       Impact factor: 5.948

6.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

7.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

8.  Diagnostic tools in tuberculous pleurisy: a direct comparative study.

Authors:  A H Diacon; B W Van de Wal; C Wyser; J P Smedema; J Bezuidenhout; C T Bolliger; G Walzl
Journal:  Eur Respir J       Date:  2003-10       Impact factor: 16.671

  8 in total
  47 in total

1.  Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples.

Authors:  Syed Beenish Rufai; Amit Singh; Parveen Kumar; Jitendra Singh; Sarman Singh
Journal:  J Clin Microbiol       Date:  2015-08-26       Impact factor: 5.948

2.  Evaluation of the Xpert MTB/RIF Ultra Assay for Direct Detection of Mycobacterium tuberculosis Complex in Smear-Negative Extrapulmonary Samples.

Authors:  Daniel Perez-Risco; David Rodriguez-Temporal; Ivan Valledor-Sanchez; Fernando Alcaide
Journal:  J Clin Microbiol       Date:  2018-08-27       Impact factor: 5.948

Review 3.  Tuberculous pleural effusions: advances and controversies.

Authors:  Morné J Vorster; Brian W Allwood; Andreas H Diacon; Coenraad F N Koegelenberg
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

4.  Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Authors:  Elizabeth Harausz; John Kafuluma Lusiba; Mary Nsereko; John L Johnson; Zahra Toossi; Sam Ogwang; W Henry Boom; Moses L Joloba
Journal:  J Clin Microbiol       Date:  2015-02-04       Impact factor: 5.948

5.  Diagnosis of extrapulmonary tuberculosis using the Xpert(®) MTB/RIF assay.

Authors:  Stephen D Lawn; Alimuddin I Zumla
Journal:  Expert Rev Anti Infect Ther       Date:  2012-06       Impact factor: 5.091

6.  Drug-resistant tubercular uveitis.

Authors:  Kusum Sharma; Aman Sharma; Reema Bansal; Paul D Fiorella; Amod Gupta
Journal:  J Clin Microbiol       Date:  2014-09-03       Impact factor: 5.948

7.  The role of technical assistance in expanding access to Xpert(®) MTB/RIF: experience in sub-Saharan Africa.

Authors:  A N Umubyeyi; F Bonsu; R Chimzizi; S Jemal; M Melese; E Ruttoh; C Mundy
Journal:  Public Health Action       Date:  2016-02-12

Review 8.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

Review 9.  Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test.

Authors:  Stephen D Lawn; Peter Mwaba; Matthew Bates; Amy Piatek; Heather Alexander; Ben J Marais; Luis E Cuevas; Timothy D McHugh; Lynn Zijenah; Nathan Kapata; Ibrahim Abubakar; Ruth McNerney; Michael Hoelscher; Ziad A Memish; Giovanni Battista Migliori; Peter Kim; Markus Maeurer; Marco Schito; Alimuddin Zumla
Journal:  Lancet Infect Dis       Date:  2013-03-24       Impact factor: 25.071

Review 10.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Hojoon Sohn; Ian Schiller; Lorie A Kloda; Catharina C Boehme; Madhukar Pai; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.